Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
Tolerogenic dendritic cells and T-regulatory cells are two immune cell populations with the potential to prevent the onset of the clinical stage of type 1 diabetes and to manage the underlying autoimmunity beginning at the time-at-onset and onwards. Initial phase I trials demonstrated that the admin...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Revisão |
| 語言: | 英语 |
| 出版: |
2019
|
| 在線閱讀: | https://doi.org/10.3389/fimmu.2019.00148 https://www.frontiersin.org/articles/10.3389/fimmu.2019.00148/pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|